Neill Andrew R
Known title: Chief Financial OfficerCIK: 0001827204
Associated companies
Transaction History
| STTK | ▲ Buy | Grant | 64,027 | $69K | 5/12/2026 | View on chart |
| STTK | ▼ Sell | Tax Withholding | 2,589 | $11K | 1/25/2026 | View on chart |
| STTK | ▼ Sell | Tax Withholding | 6,660 | $32K | 1/10/2026 | View on chart |
| STTK | ▲ Buy | Grant | 64,027 | $56K | 8/25/2025 | View on chart |
| STTK | ▲ Buy | Grant | 56,500 | $0 | 1/10/2024 | View on chart |
| STTK | ▼ Sell | Tax Withholding | 2,470 | $25K | 1/10/2024 | View on chart |
| STTK | ▼ Sell | Open Market | 25,000 | $250K | 1/10/2024 | View on chart |
| STTK | ▲ Buy | Grant | 34,925 | $0 | 1/25/2023 | View on chart |
| STTK | ▲ Buy | Grant | 33,325 | $0 | 1/10/2022 | View on chart |
| STTK | ▲ Buy | Option Exercise | 20,000 | $59K | 11/11/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
UBS initiates coverage on Shattuck Labs with $17 price target
UBS has started covering Shattuck Labs, assigning a price target of $17. This new analyst view comes as the company prepares to present research at UEG Week 2026. The stock is currently trading near its 52-week low, making this fresh institutional attention a notable development for the company.
UBS initiates coverage on Shattuck Labs with $17 price target. UBS has started covering Shattuck Labs, assigning a price target of $17. This new analyst view comes as the company prepares to present research at UEG Week 2026. The stock is currently trading near its 52-week low, making this fresh institutional attention a notable development for the company.